Abbott Laboratories Financial Overview
Abbott Laboratories's market cap is currently $187.89B. The company's EPS TTM is €1.1066118310000002; its P/E ratio is 14.67; and it has a dividend yield of 1.89%. Abbott Laboratories is scheduled to report earnings on October 15, 2025, and the estimated EPS forecast is €1.27. See an overview of income statement, balance sheet, and cash flow financials.
